Global Blood Therapeutics Overview

Global Blood Therapeutics Total Revenue

Revenue analysis for GBT.

Quarterly Revenue

$71.55M

↑ 50.46% YoY

As of Jun 2022

Annual Revenue (TTM)

$234.86M

↑ 42.53% YoY

Trailing 12 months ending Jun 2022

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin